AI-based Glaucoma Screening in Community Health Centers
This study is looking at how well an eye screening program works in Federally Qualified Health Centers (FQHCs), which are community health clinics. The program uses an artificial intelligence (AI) tool called AI-RONA to help screen for glaucoma and other eye problems like diabetic retinopathy (eye damage from diabetes), cataracts (cloudy eye lens), and vision loss. The study wants to see if this screening program helps identify people who might have these eye conditions and if they then go for follow-up eye exams. You might be able to join if you are African American or Hispanic and over 40, non-Hispanic white and over 50, or over 18 with diabetes or a family history of glaucoma. The study aims to enroll 1800 participants.
- Study design
- This interventional study plans to enroll 1800 participants. It will compare the rate of eye conditions detected with this screening program to clinics without the program.
- What's involved
- Participants will undergo glaucoma screening using an AI-algorithm, which includes an Artificial Intelligence Remote Optic Nerve Assessment (AI-RONA). The study measures outcomes up to 4 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed to see if they attend a follow-up eye exam by an optometrist or ophthalmologist, with this measured up to 4 months after screening.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Cynthia Owsley, PhD · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Rate of participants where the glaucoma screening protocol leads to a screening diagnosis of glaucomaup to 2-3 days
Primary care provider will make a screening diagnosis of glaucoma associated disease based on the results of the screening
- Rate of participants who decide to attend the follow up exam by optometrist or ophthalmologistup to 4 months
If diagnosed with any of the above conditions, and primary car provider recommends follow-up care with an optometrist or ophthalmologist, whether participant actually attends the exam
- Rate of participants where the screening protocol leads to a screening diagnosis of cataract, diabetic retinopathy, or visual acuity impairmentup to 2-3 days
Based on results of screening, the primary care provider will be able to make a screening diagnosis of cataract, diabetic retinopathy or visual acuity impairment
- Compare cost of screening program in FQHC to the cost of an ophthalmologist or optometrist guided assessmentup to 4 years
Compare the cost of AI based interventions relying on optic disc photos alone, OCT alone, both imaging modalities, and imaging with standard vision tests performed by an ophthalmologist or optometrist guided program